Abstract

The muscarinic-cholinergic system is involved in the pathophysiology of bipolar disorder (BD), and contributes to attention and the top-down and bottom-up cognitive and affective mechanisms of emotional processing, functionally altered in BD. Emotion processing can be assessed by the ability to inhibit a response when the content of the image is emotional. Impaired regulatory capacity of cholinergic neurotransmission conferred by reduced M2-autoreceptor availability is hypothesized to play a role in elevated salience of negative emotional distractors in euthymic BD relative to individuals with no history of mood instability. Thirty-three euthymic BD type-I (DSM-V-TR) and 50 psychiatrically-healthy controls underwent functional magnetic resonance imaging (fMRI) and an emotion-inhibition paradigm before and after intravenous cholinergic challenge using the acetylcholinesterase inhibitor, physostigmine (1 mg), or placebo. Mood, accuracy, and reaction time on either recognizing or inhibiting a response associated with an image involving emotion and regional functional activation were examined for effects of cholinergic challenge physostigmine relative to placebo, prioritizing any interaction with the diagnostic group. Analyses revealed that (1) at baseline, impaired behavioral performance was associated with lower activation in the anterior cingulate cortex in BD relative to controls during emotion processing; (2) physostigmine (vs. placebo) affected behavioral performance during the inhibition of negative emotions, without altering mood, and increased activation in the posterior cingulate cortex in BD (vs. controls); (3) In BD, lower accuracy observed during emotion inhibition of negative emotions was remediated by physostigmine and was associated with cingulate cortex overactivation. Our findings implicate abnormal regulation of cholinergic neurotransmission in the cingulate cortices in BD, which may mediate exaggerated emotional salience processing, a core feature of BD.

Highlights

  • Bipolar disorder (BD) is a severe and burdensome psychiatric condition involving recurrent depressive and manic episodes and overall instability in regulating emotions [1]

  • Emotion recognition and inhibition functional magnetic resonance imaging (fMRI) task An emotion-inhibition fMRI task was chosen to assess regional functional activation involved in valence assessment of emotional content [48, 49], consisting of 180 pseudo-randomized trials belonging to two groups, emotion-recognition and emotion-inhibition trials, and three emotional valences for a total of six event types (International Affective Picture System database, IAPS [50])

  • The imaging analysis featured a total of 33 participants with BD type I (n = 29) and type II (n = 4) and 50 controls aged 18–64; groups were matched for age and gender and education level (Table 1)

Read more

Summary

Introduction

Bipolar disorder (BD) is a severe and burdensome psychiatric condition involving recurrent depressive and manic episodes and overall instability in regulating emotions [1]. The severity and burden of bipolar affective dysregulation affects the quality of life of approximately 1–3% of the world population [2]; the neurobiological basis leading to the illness remains unclear. It is important to identify neural biomarkers with predictive validity for therapeutic response to enhance diagnostic specificity and guide treatment decisions, to identify the different biological subtypes of BD that may exist and to address the biological heterogeneity extant within mood disorders. Dysregulated emotional responses can lead to pathological mood states. Among the array of emotion-related impairments in BD, a hallmark of this disorder is the distorted information processing or attentional allocation toward emotional stimuli [5].

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call